AR103676A1 - ARNi COMPOSITIONS CONTAINING A PATTERN TYPE 3 PHOSPHOLIPASE DOMAIN (PNPLA3) AND ITS METHODS OF USE - Google Patents

ARNi COMPOSITIONS CONTAINING A PATTERN TYPE 3 PHOSPHOLIPASE DOMAIN (PNPLA3) AND ITS METHODS OF USE

Info

Publication number
AR103676A1
AR103676A1 ARP160100392A ARP160100392A AR103676A1 AR 103676 A1 AR103676 A1 AR 103676A1 AR P160100392 A ARP160100392 A AR P160100392A AR P160100392 A ARP160100392 A AR P160100392A AR 103676 A1 AR103676 A1 AR 103676A1
Authority
AR
Argentina
Prior art keywords
pnpla3
methods
arni
compositions containing
pattern type
Prior art date
Application number
ARP160100392A
Other languages
Spanish (es)
Inventor
Hinkle Gregory
Fitzgerald Kevin
Original Assignee
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc
Publication of AR103676A1 publication Critical patent/AR103676A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Agentes de ARNi, por ejemplo, agentes de ARNi de cadena doble, dirigidos a un gen que contiene un dominio fosfolipasa tipo patatina 3 (PNPLA3) y métodos de uso de dichos agentes de ARNi para inhibir la expresión de un gen PNPLA3 y métodos de tratamiento de sujetos con una enfermedad de hígado de graso no alcohólico (NAFLD) y/o un trastorno asociado a PNPLA3.RNAi agents, for example, double-stranded RNAi agents, targeting a gene that contains a patatin 3 phospholipase domain (PNPLA3) and methods of using said RNAi agents to inhibit the expression of a PNPLA3 gene and treatment methods of subjects with a non-alcoholic fatty liver disease (NAFLD) and / or a disorder associated with PNPLA3.

ARP160100392A 2015-02-13 2016-02-12 ARNi COMPOSITIONS CONTAINING A PATTERN TYPE 3 PHOSPHOLIPASE DOMAIN (PNPLA3) AND ITS METHODS OF USE AR103676A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562115724P 2015-02-13 2015-02-13

Publications (1)

Publication Number Publication Date
AR103676A1 true AR103676A1 (en) 2017-05-24

Family

ID=58941323

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100392A AR103676A1 (en) 2015-02-13 2016-02-12 ARNi COMPOSITIONS CONTAINING A PATTERN TYPE 3 PHOSPHOLIPASE DOMAIN (PNPLA3) AND ITS METHODS OF USE

Country Status (1)

Country Link
AR (1) AR103676A1 (en)

Similar Documents

Publication Publication Date Title
CL2019001388A1 (en) Compositions of Arni de Serpin1 and its methods of use.
UY35582A (en) COMPOSITIONS OF ARNi DE SERPINA1 AND ITS METHODS OF USE
AR121312A2 (en) RNAi AGENTS, COMPOSITIONS AND METHODS OF USE THERETO FOR TREATING DISEASES ASSOCIATED WITH TRANSTHYRETIN (TTR)
CL2023002358A1 (en) Arni constructs to inhibit pnpla3 expression and their methods of use
CL2021002998A1 (en) arni compositions against tmprss6 and methods for their use (divisional application no. 03440-2015)
UY36357A (en) COMPOSITIONS AND METHODS FOR THE INHIBITION OF HAO1 GENE EXPRESSION (OXIDASE HYDROXYACYDE 1 (OXIDASE GLYCOLATE))
CL2020002401A1 (en) Arni compositions of 17 b-hydroxysteroid dehydrogenases type 13 (hsd17b13) and methods of use thereof.
NI201400046A (en) IARN AGENTS, COMPOSITIONS AND METHODS OF USE OF THE SAME TO TREAT TRANSTIRETIN-ASSOCIATED DISEASES (TTR)
WO2016130806A3 (en) Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
BR112016029041A8 (en) use of a glutaminase inhibitor, pharmaceutical composition and pharmaceutical kit
BR112016026950A2 (en) angiotensinogen (agt) RNA compositions and methods of use thereof
CO2017013065A2 (en) Diaciglycerol acyltransferase 2 modulators (dgat2)
UY38503A (en) ARNI CONSTRUCTS TO INHIBIT THE EXPRESSION OF PNPLA3 AND METHODS OF USE OF THEM
UY37800A (en) IRNA AGENTS FOR THE INHIBITION OF ALFA-ENaC EXPRESSION AND METHODS OF USE
AR115960A1 (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE LECT2 GENE
AR103676A1 (en) ARNi COMPOSITIONS CONTAINING A PATTERN TYPE 3 PHOSPHOLIPASE DOMAIN (PNPLA3) AND ITS METHODS OF USE
CU20170134A7 (en) 2-THIOPIRIMIDINONES
AR110225A1 (en) COMPOSITIONS OF ARNi DE SERPINA1 AND ITS METHODS OF USE
CL2018002946A1 (en) Methods for developing nutritional formulations.
CR20150644A (en) COMPOSITIONS OF ARNI SERAPINE 1 AND ITS METHODS OF USE
CL2017002646A1 (en) Compositions of serni arni1 and their methods of use (divisional application No. 3441-2015).
CL2017000872A1 (en) Compositions and methods for the inhibition of the gene expression of hao1 (hydroxy acid oxidase 1 (glycolate oxidase)
AR096390A1 (en) COMPOSITIONS OF ARNi DE SERPINA1 AND ITS METHODS OF USE
AR104542A1 (en) COMPOSITIONS OF ARNi AGAINST FACTOR XII (HAGEMAN FACTOR) (F12), CALICREIN B, PLASMATIC (FLETCHER FACTOR) 1 (KLKB1), AND QUININOGEN 1 (KNG1) AND METHODS OF USE OF THE SAME
UY36350A (en) COMPOUND DERIVED FROM PIRAZOL FOR TREATMENT OR PREVENTION OF CHAGAS DISEASE.